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graphical ABSTRACT 
Five new 2,9,9-trimethyl-6,7,8,9-tetrahydro-benzocyclohepten-5-ylidene-amine derivatives 
(16a-16e) were synthesized from α-dehydro-ar-himachalene (11) that was originally prepared 
from an isomeric mix- ture of α, β and γ himacha-
lenes (10), the abundant sesquiterpenes of Cedrus 
deodara essential oil. In addition, different aryl hi-
machalenes derivatives (9, 12, 14 and 15) were also 
formed from 11. The structures of the synthe-
sized compounds were confirmed on the basis of 
their NMR, IR and mass spectral data. The 
prepared compounds were tested against a group 
of sixteen organisms including gram positive and 
gram negative bacterial and fungal strains. The in-
troduction of a series of substituted imine groups in-
to aryl himachalenes at 5th position (16a-16e) en-
hanced antimicrobial activity as compared to the aromatized derivatives (9, 12, 14 and 15) 
against gram-positive bacteria Bacillus subtilis, Micrococcus luteus and Staphylococcus aure-
us, and mycotoxigenic fungi Aspergillus parasiticus, A. ochraceous and A. sydowii. 
 
Keywords: himachalenes, Cedrus deodara, essential oil, antimicrobial activity 
 
 
INTRODUCTION 
The essential oil of the Himalayan Cedar 
(Cedrus deodara) plays an important role of 
starting material in the fragrance and phar-
maceutical industries (Hossini et al., 2011; 
Bhushan et al., 2006). This oil contains three 
major sesquiterpenes named α-cis-, β-, and γ-
cis-himachalenes having hexahydrobenzocy-
cloheptene as basic skeleton (Chaudhary et 
al., 2009). Benzocycloheptene and their de-
rivatives are the biologically potent class of 
bicyclic framework and are attractive syn-
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thetic targets for organic and medicinal 
chemists (Chaudhary et al., 2012). These de-
rivatives have been prepared by different 
routes, such as the enlargement of six-
membered rings, cyclization (Lynch and 
Macdonald, 2009; Hattori and Tanaka, 2002) 
and coupling reactions or from benzocyclo-
heptanone (Bohlmann et al., 2006) involving 
either oxime formation, reductive amination, 
through azide formation, α-bromination or 
cyanoboration (Nedelec et al., 1979, Nakano 
et al., 2010; Chow et al., 2009; Tandon et al., 
2004). Nitrogen containing substituted ben-
zocycloheptenes have been found to act as 
ORL-1 receptor agonists 1 (Figure 1) and β3 
adrenergic receptor agonists 2, α-sympatho-
mimetic, anorexigenic 3, antidepressant 4, 
analgesic and antiarrhythmic agents 5. These 
were also reported for modulation of small-
conductance calcium-activated potassium 
channels 6, for treatment of psoriasis 7, car-
diovascular 8, and neurodegenerative diseas-
es (Chaudhary et al., 2012; Sorensen et al., 
2008; Zaratin et al., 2004; Tandon et al., 
2004). 
The reactivity of himachalenes has been 
studied extensively since their isolation by 
Dev and co-workers and subjected to various 
chemical modifications such as cyclopropa-
nation, oxidation, hydroxylation and epoxi-
dation and total syntheses to improve their 
biological activities (Chaudhary et al., 2012; 
Daoubi et al., 2005; Hossini et al., 2011; Jo-
seph and Dev, 1961). On reaction with vari-
ous aromatizing agents, mixture of products 
was yielded (Shankaranarayan et al., 1977). 
Chemical analysis of the pheromone gland 
extract of sandfly and flea beetles revealed 
ar-himachalene 9, himachalene and their me-
thyl derivatives as sex pheromones (Figure 
1) (Zilkowski et al., 2006). The insecticidal 
principles, himachalol and β-himachalene 
showed potency against pulse beetle and 
housefly (Singh and Agarwal, 1988). Hy-
droxylated derivatives of β-himachalene pos-
sess promising antifungal potential against 
phytopathogen Botrytis cinerea (Daoubi et 
al., 2005). 
In continuation of our previous work 
(Chaudhary et al., 2012) to synthesize nitro-
gen containing benzocycloheptene ana-
logues, herein, we have developed a simple 
and practical pathway for the synthesis of 
important similar benzocycloheptene ana-
logues from α-dehydro-ar-himachalene (11) 
(Figure 2) and evaluated them for antimicro-
bial activities against opportunistic human 
bacterial and fungal pathogens. 
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Figure 1: Structures of biologically potent ben-
zocycloheptene analogues  
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Figure 2: Synthesis of ar-himachalene derivat-
ives from α-dehydro-ar-himachalene 
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MATERIALS AND METHODS 
General 
All NMR spectra were recorded on a 
Bruker Avance-300 instrument (300 MHz 
1H, 75.46 MHz 13C) using CDCl3 and TMS 
as solvent and reference, respectively. Chem-
ical shifts (δ) were given in parts per million. 
Silica gel (60–120 mesh) for column chro-
matography, TLC silica gel 60 F254 plates, 
silica gel (H) and all other chemicals and 
solvents used were purchased from Merck 
India Ltd. DMSO and ampicillin and nysta-
tin was purchased from Sigma Aldrich Co., 
MO, USA and HiMedia Laboratories Pvt. 
Ltd., Mumbai, India respectively. GC-MS 
analysis was conducted on a GC-MS 
(QP2010) Shimadzu gas chromatograph 
mass spectrometer. A carbowax phase, BP-
20 capillary column (30 m × 0.25 mm i.d. 
with film thickness 0.25 μm) was used with 
helium as a carrier gas at a flow rate of 1.1 
ml/min on split mode (1:50). The injector 
temperature was programmed from 40-
220 °C at 4 °C/min rise with 4 min hold at 
40 °C and 15 min hold at 220 °C and inter-
face temperatures were 250 °C. Ion source 
temperature was 200 °C. Sample (20 μl) was 
dissolved in 2 ml GC grade dichloromethane 
and sample injection volume was 2 μl. IR 
spectra were obtained on a Nicolet 5700 
FTIR (Thermo, USA) spectrophotometer in 
the region 4000-400 cm-1 using KBr discs. 
Mass spectra were recorded on a Waters 
QTOF-MS with ESI using Waters Mass lynx 
4.1 software. 
 
General procedure for synthesis of 5H-
benzocycloheptene 11-13  
To a solution of himachalenes (10) (1 g, 
4.902 mmol) in dry benzene (30 ml) was 
added DDQ (1.1 g, 9.804 mmol) and the 
mixture was stirred at reflux for 24 h under 
N2. The solvent was removed under reduced 
pressure. The reaction was then quenched by 
adding 5 % sodium bicarbonate solution and 
extracted with ethyl acetate. Organic layer 
was finally concentrated and chromato-
graphed on silica gel (heptane 100 %) to af-
ford 11, 12 and 13 as colorless oil. 
 
2,9,9-Trimethyl-5-methylene-6,7,8,9-
tetrahydro-5H-benzocycloheptene 11 
The spectroscopic data of compound 11 
was reported earlier (Chaudhary et al., 2012). 
 
3,5,5,9-Tetramethyl-5H-benzocycloheptene 
12 
Colorless oil (yield 21 %). IR (KBr): λmax 
= 2955, 2924, 2873, 1721, 1283, 774 cm-1. 
1H NMR (300 MHz, CDCl3) δ = 7.59 (1H, d, 
J = 7.6 Hz), 7.26 (1H, s), 7.16 (1H, d, J = 7.5 
Hz), 6.40-6.42 (1H, m), 6.00-6.05 (1H, m), 
5.61 (1H, d, J = 10.2 Hz), 2.47 (6H, s), 1.41 
(6H, s). 13C NMR (75.4 MHz, CDCl3) δ = 
144.9, 139.5, 138.4, 138.1, 134.0, 126.8, 
125.6, 125.1, 124.2, 123.8, 37.9, 29.3, 25.5, 
21.0. GC–MS (70 eV): tR = 35.704 min, m/z 
200 [M+, C15H18], 198, 183, 168, 153, 141, 
128, 115, 83.  
 
3,5,5-Trimethyl-9-methylene-
2,4a,5,6,7,8,9,9a-octahydro-1H-
benzocycloheptene 13 
Colorless oil (yield 15 %). IR (KBr): λmax 
= 3056, 1606, 1643, 1362, 720, 945 cm-1. 1H 
NMR (300 MHz, CDCl3) δ = 5.50 (1H, s), 
4.79 (1H, s), 4.74 (1H, s), 2.83 (1H, m), 
1.77-2.16 (7H, m), 1.69 (3H, s), 1.18-1.40 
(4H, m), 1.02 (6H, s); 13C NMR (75.4 MHz, 
CDCl3) δ = 157.9, 133.9, 123.8, 111.3, 47.9, 
40.0, 36.7, 38.4, 36.6, 32.2, 28.3, 26.7, 25.2, 
24.2. GC–MS (70 eV): tR = 31.627 min, m/z 
204 [M+, C15H24], 189, 175, 161, 147, 134, 
119, 105, 93, 79, 69, 55.  
 
2,5,9,9-Tetramethyl-6,7,8,9-tetrahydro-5H-
benzocycloheptene 9 
To a solution of 11 (45 mg, 0.225 mmol) 
in 2 ml of ethyl acetate and methanol (1:1, 
v/v) was added 40 mg of 10 % palladium on 
activated carbon. The mixture was stirred for 
5 h under hydrogen, the reaction mixture was 
filtered, and the filtrate was evaporated. The 
crude product was purified by silica gel col-
umn chromatography (heptane 100 %) to 
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give compound 9 as colorless oil (yield 
80 %). IR (KBr): λmax = 3043, 2876, 2853, 
1566, 1292, 905 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.29 (1H, s), 7.22 (1H, d, J = 7.8 
Hz), 7.08 (1H, d, J = 7.7 Hz), 3.34-3.39 (1H, 
m), 2.41 (3H, s), 1.85-1.92 (2H, m), 1.57- 
1.63 (2H, m), 1.52 (3H, s), 1.45 (2H, m) 1.43 
(6H, s). 13C NMR (75.4 MHz, CDCl3) δ = 
147.9, 141.4, 135.1, 128.4, 126.7, 125.6, 
41.3, 39.7, 36.7, 34.7, 34.2, 24.3, 21.4, 21.2. 
GC–MS (70 eV): tR = 34.401 min, m/z 202 
[M+, C15H22], 187, 159, 145, 131, 119, 105, 
91, 77, 57.  
 
3,5,5,9-Tetramethyl-6,7-dihydro-5H-
benzocycloheptene 14 
To a solution of 12 (46 mg, 0.232 mmol) 
in 2 ml of ethyl acetate and methanol (1:1, 
v/v) was added 40 mg, of 10 % palladium on 
activated carbon. The mixture was stirred for 
6 h under hydrogen, the reaction mixture was 
filtered, and the filtrate was evaporated. The 
crude product was purified by silica gel col-
umn chromatography (heptane 100 %) to 
give compound 14 as colorless oil (yield 
75 %). The compound 14 also yielded com-
pound 9 by method as described above (yield 
80 %). IR (KBr): λmax = 3103, 2955, 2876, 
1450, 1281, 872 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 7.19-7.29 (2H, m), 7.05-7.14 
(1H, m), 5.94 (1H, m), 2.44 (3H, s), 2.40 
(2H, m), 2.03 (3H, s), 1.84 (2H, m), 1.40 
(6H, s). 13C NMR (75.4 MHz, CDCl3) δ = 
146.6, 138.1, 137.3, 135.8, 127.7, 126.7, 
126.5, 48.0, 38.2, 31.4, 26.3, 24.2, 21.6. GC–
MS (70 eV): tR = 34.085 min, m/z 200 [M+, 
C15H20], 185, 171, 157, 143, 128, 115, 105, 
91, 77. 
 
2,9,9-Trimethyl-6,7,8,9-tetrahydro-
benzocyclohepten-5-one 15 
The compound 11 (95 mg, 0.475 mmol) 
and osmium tetroxide (1 mol %) in THF (0.5 
ml) were added over a period of 30 min to a 
solution of sodium periodate (550.9 mg, 
2.575 mmol) in water (0.5 ml). The mixture 
was stirred for further 20 h at room tempera-
ture. Extraction with ethyl acetate and dieth-
yl ether followed by filtration through basic 
alumina and evaporation gave a yellow sem-
isolid which on purification by silica gel col-
umn chromatography (hexane:EtOAc 97:3) 
gave 15 as light yellow semisolid (yield 
73 %). IR (KBr): λmax = 2967, 2925, 2850, 
1730, 800 cm-1. 1H NMR (300 MHz, CDCl3) 
δ = 7.60-7.67 (1H, m), 7.52-7.56 (1H, m), 
7.38-7.41 (1H, m), 3.06 (2H, m), 2.69 (3H, 
s), 2.45-2.52 (2H, m), 2.18-2.24 (2H, m), 
1.66 (6H, s). 13C NMR (75.4 MHz, CDCl3) δ 
= 208.5, 147.0, 140.7, 138.0, 128.5, 126.7, 
126.3, 42.5, 40.1, 38.5, 31.6, 23.3, 21.4. HR-
ESI-MS: 203.3000 ([M+H]+, C14H18O+; calc. 
m/z 203.3001).  
 
General procedure for the synthesis of com-
pounds 16a-16e 
A mixture of 15 (56 mg, 0.277 mmol) 
and benzylamine (32.6 mg, 0.305 mmol) was 
uniformly adsorbed on the surface of activat-
ed silica gel (0.5 g) by dropwise addition un-
der stirring, and the mixture was then stirred 
at 60 °C for 6 h to allow complete formation 
of the corresponding imine. The reaction was 
monitored by TLC and the reaction mixture 
was extracted with ethyl acetate. The organic 
layer finally concentrated and then chro-
matographed on silica gel (hexane:EtOAc 
90:10) to afford 16a.  
 
Benzyl-(2,9,9-trimethyl-6,7,8,9-tetrahydro-
benzocyclohepten-5-ylidene)-amine 16a 
Light brown semisolid (yield 74 %). IR 
(KBr): λmax = 3009, 2838, 2828, 1669, 1629, 
1369, 843 cm-1. 1H NMR (300 MHz, CDCl3) 
δ = 6.86-7.50 (8H, m), 4.37-4.63 (1H, m), 
2.38 (3H, s), 1.77-1.84 (2H, m), 1.45 (2H, 
m), 1.30 (6H, s), 1.24 (2H, m). 13C NMR 
(75.4 MHz, CDCl3) δ = 176.8, 146.5, 141.0, 
138.3, 135.8, 128.8, 128.2, 127.4, 127.2, 
126.9, 126.7, 57.9, 41.8, 38.9, 32.2, 30.2, 
25.4, 22.0. HR-ESI-MS: 292.4380 ([M+H]+, 
C21H25N+; calc. 292.4378).  
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Cyclohexyl-(2,9,9-trimethyl-6,7,8,9-
tetrahydro-benzocyclohepten-5-ylidene)-
amine 16b 
Prepared as described for 16a; starting 
from 15 (50 mg, 0.248 mmol) and cyclohex-
yl amine (27 mg, 0.272 mmol) and after pu-
rification with silica gel column chromatog-
raphy (hexane:EtOAc, 90:10) to afford 16b 
as light brown semisolid (yield 78 %). IR 
(KBr): λmax = 3177, 2992, 2813, 1708, 1633, 
1197, 920 cm-1. 1H NMR (300 MHz, CDCl3) 
δ = 7.15 (1H, m), 7.01 (1H, m), 6.83 (1H, 
m), 2.57 (1H, m), 2.38 (3H, s), 2.05-2.07 
(2H, m), 1.70-1.76 (4H, m), 1.58-1.65 (7H, 
m), 1.40-1.42 (3H, m), 1.28 (6H, s). 13C 
NMR (75.4 MHz, CDCl3) δ = 174.0, 140.0, 
138.1, 136.0, 129.2, 127.4, 126.6, 51.0, 41.4, 
38.9, 32.3, 32.1, 31.4, 30.1, 25.3, 23.0, 21.9. 
HR-ESI-MS: 284.4588 ([M+H]+, C20H29N; 
calc. 284.4589).  
 
Isobutyl-(2,9,9-trimethyl-6,7,8,9-tetrahydro-
benzocyclohepten-5-ylidene)-amine 16c 
Prepared as described for 16a; starting 
from 15 (99 mg, 0.491 mmol) and isobutyl 
amine (39.5 mg, 0.539 mmol) and after puri-
fication with silica gel column chromatog-
raphy (hexane:EtOAc 90:10) to afford 16c as 
light brown semisolid (yield 71 %). IR 
(KBr): λmax = 3044, 2872, 2990, 1523, 1657, 
1284, 791 cm-1. 1H NMR(300 MHz, CDCl3) 
δ = 7.03 (2H, m), 6.85 (1H, m), 2.38 (3H, s), 
2.12 (1H, m), 1.92 (1H, m), 1.70(4H, m), 
1.41 (2H, m), 1.27 (12H, s). 13C NMR (75.4 
MHz, CDCl3) δ = 174.0, 145.8, 138.0, 136.1, 
129.1, 127.3, 126.6, 61.8, 41.0, 38.9, 32.0, 
31.7, 31.2, 30.3, 25.0, 21.8. IR. HR-ESI-MS: 
258.4210 ([M+H]+, C21H25N+; calc. 
258.4216).  
 
Methyl-(2,9,9-trimethyl-6,7,8,9-tetrahydro-
benzocyclohepten-5-ylidene)-amine 16d 
Prepared as described for 16a; starting 
from 15 (100 mg, 0.495 mmol), methyl 
amine (17 mg, 0.545 mmol) and after purifi-
cation with silica gel column chromatog-
raphy (hexane:EtOAc 95:05) to afford 16d 
as light brown semisolid (yield 79 %). IR 
(KBr): λmax = 3020, 2845, 2880, 1683, 1697, 
1254, 870 cm-1. 1H NMR (300 MHz, CDCl3) 
δ = 7.06-7.20 (3H, m), 2.36 (3H, s), 2.12 
(3H, s), 1.96 (2H, m), 1.72 (4H, m), 1.34 
(6H, s). 13C NMR (75.4 MHz, CDCl3) δ = 
174.3, 147.8, 136.7, 130.4, 128.8, 126.9, 
126.6, 41.0, 38.4, 37.8, 31.6, 30.1, 26.5, 
21.9. HR-ESI-MS: 216.3414 ([M+H]+, 
C15H22N+; calc. 216.3419).  
 
(2-Morpholin-4-yl-ethyl)-(2,9,9-trimethyl-
6,7,8,9-tetrahydro-benzocyclohepten-5-
ylidene)-amine 16e 
Prepared as described for 16a; starting 
from 15 (106 mg, 0.525 mmol), methyl 
amine (75.2 mg, 0.578 mmol) and after puri-
fication with silica gel column chromatog-
raphy (hexane:EtOAc 50:50) to afford 16e as 
light brown semisolid (yield 65 %). IR 
(KBr): λmax = 2817, 2791, 1650, 1629, 1486, 
1397, 1107 cm-1. 1H NMR (300 MHz, 
CDCl3) δ = 6.90-7.27 (3H, m), 3.57 (6H, m), 
2.65 (2H, m), 2.31 (4H, m), 2.23 (3H, s), 
1.50-1.98 (6H, m), 1.20 (6H, s). 13C NMR 
(75.4 MHz, CDCl3) δ = 170.6, 147.1, 140.5, 
136.8, 129.7, 127.3, 126.0, 66.7, 61.2, 53.5, 
48.7, 40.8, 38.5, 36.2, 31.0, 25.9, 21.1. HR-
ESI-MS: 315.4709 ([M+H]+, C20H31N2O+; 
calc. 315.4729).  
 
Antimicrobial assays 
Antimicrobial activity was tested against 
a panel of sixteen organisms: gram-positive 
bacteria- Bacillus subtilis (MTCC 121), 
Micrococcus luteus (MTCC 2470), 
Staphylococcus aureus (MTCC 96), Gram-
negative bacteria- Burkholderia cepacea 
(MTCC 438), Escherichia coli (MTCC 43), 
Klebsiella pneumoniae (MTCC 109), 
Pseudomonas aeruginosa (MTCC 424), 
Enterobacter cloacae (MTCC 509) and 
fungal strains Candida albicans (MTCC 
3017), Issatchenkia orientalis (MTCC 231), 
Aspergillus flavus (MTCC 277), A. niger 
(MTCC 404), A. parasiticus (MTCC 2797), 
A. sydowii (MTCC 4335) and A. ochraceous 
(MTCC 4893), Trichophyton rubrum 
(MTCC 296) procured from the Microbial 
Type Culture Collection at the Institute of 
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Microbial Technology, India. Broth microdi-
lution method was used for the determination 
of minimum inhibitory concentration (MIC) 
and minimum microcidal concentration 
(MMC) in triplicates (Cos et al., 2006; 
Sharma et al., 2009). Test compounds were 
dissolved in DMSO to prepare the stock so-
lutions. Two-fold dilution series of test com-
pounds were prepared for the dose range 
3000-23.4 µg/ml in sterilized Mueller-
Hinton broth (MHB) for bacteria and 
Sabouraud dextrose broth (SDB) for fungi in 
96-well microtiter plates. Freshly grown bac-
terial and fungal cultures adjusted to 1.0×105 
cfu/ml with sterile normal saline were used 
to inoculate the plates. The uninoculated 
sterilized medium with and without DMSO 
served as control. Ampicillin and nystatin 
served as positive controls for bacteria and 
fungi, respectively. The plates were incubat-
ed at 37 °C for 24 h for bacteria, 28 °C for 
24 h for C. albicans, and 28 °C for 5 days for 
rest of the fungi. The plates were incubated 
for 12 h after addition of 5 µl resazurin indi-
cator solution (5mg/ml) to each well. The 
experiment included three replicates for each 
plate. The lowest concentration which pre-
vented colour change from purple to pink 
was recorded as MIC, while the lowest con-
centration completely killing the inoculated 
microorganism was recorded as MMC.  
 
RESULTS AND DISCUSSION 
To the best of our knowledge, the hima-
chalenes have not yet been thoroughly inves-
tigated, and there are few methods reported 
involving synthesis of benzocycloheptene 
derivatives from himachalenes by simple 
pathway (Chaudhary et al., 2012; Pandey 
and Dev, 1968). The synthesis was carried 
out by the conversion of himachalenes 10 in-
to benzocycloheptene derivatives namely α-
dehydro-ar-himachalene 11, bisdehydro-ar-
himachalene 12 and α-himachalene 13 by 
oxidative aromatization. In this study, α-
dehydro-ar-himachalene 11 is used as pre-
cursor for the synthesis of substituted benzo-
cycloheptenone. The benzocycloheptenone 
acts as an intermediate for synthesis of ben-
zocycloheptene moiety and have been inves-
tigated for a wide spectrum of biological ac-
tivities like cytotoxic, anticancer, antimicro-
bial and antagonistic activity (Bohlmann et 
al., 2006). It was mostly synthesized by cy-
clization of phenyl pentanoic acid (Liu et al., 
2008). However, here, for the first time we 
conducted the synthesis of benzocyclohep-
tenone starting from α-dehydro-ar-hima-
chalene 11. Oxidation of terminal alkene of 
11 was attempted with different oxidizing 
agents such as KMnO4, Hg(OAc)2, RuCl3/ 
NaIO4, Pd(OAc)2/O2 that led to the for-
mation of mixture of products. Finally, the 
oxidation of exocyclic double bond of 11 
was optimized with NaIO4 and OsO4 in wa-
ter:THF (1:1, v/v) for 20 h at room tempera-
ture to produce corresponding benzocyclo-
heptenone (15) in 73 % yield (Figure 2).  
As nitrogen containing amino and imino 
benzocycloheptenes have been investigated 
to show diverse range of biological activi-
ties, the conversion of carbonyl moiety of 
benzocycloheptenone 15 into imino substi-
tuted benzocycloheptenes 16 was tried with 
reported conditions in several solvents such 
as toluene, benzene, DMF, THF but no suc-
cessful results were obtained. Using dry sili-
ca gel (H) as a lewis acid and an appropriate 
amine gave good conversion of imine deriva-
tives of benzocycloheptene (Figure 2) and no 
work up was required before purification 
through column chromatography. The mix-
ture was directly transferred to column and 
purification was performed with hex-
ane:EtOAc (90:10). With the optimized reac-
tion conditions in hand, the scope of this re-
action was then probed with a range of dif-
ferent amines (Table 1). Under similar condi-
tions, the reactions of benzocyclohepten-5-
one 15 with corresponding amines proceeded 
smoothly to form novel imine compounds 
16a-16e in 65-79 % yields (Table 1, entries 
1-5). 
The aryl himachalene was earlier pre-
pared from mixture of himachalenes or 3-
methylacetophenone (Abouhamza et al., 
2001). While in the present study aryl hima-
chalene 9 was obtained by catalytic hydro-
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genation of α-dehydro-ar-himachalene 11 
with Pd/C in ethyl acetate and methanol (1:1, 
v/v) in 80 % yield. Aryl himachalene 9 was 
also obtained by dual reduction of bisdehy-
dro-ar-himachalene 12 with Pd/C in ethyl 
acetate and methanol via γ-dehydro-ar-
himachalene 14 (Figure 2). The structures of 
synthesized compounds were established on 
the basis of IR, NMR and mass spectro-
metry. 
The antimicrobial activity of all the hi-
machalene derivatives (9-15, 16a-16e) were 
tested against a panel of sixteen organisms: 
gram-positive bacteria- B. subtilis, M. luteus, 
S. aureus, gram-negative bacteria- B. ce-
pacea, E. coli, K. pneumoniae, P. aerugino-
sa, E. cloacae and fungal strains C. albicans, 
I. orientalis, A. flavus, A. niger, A. parasiti-
cus, A. sydowii, A. ochraceous and T. 
rubrum. It was observed that the aromatized 
himachalenes (ar-himachalene 9, α-dehydro-
ar-himachalene 11, bisdehydro-ar-himacha-
lene 12 and γ-dehydro-ar-himachalene 14) 
did not show antimicrobial activity against 
the gram-negative bacteria B. cepacea, E. 
coli, K. pneumoniae and P. aeruginosa even 
at a high concentration of 3000 µg/ml (Table 
2). However, bis dehydro-ar-himachalene 12 
exhibited antibacterial activity against the 
gram-positive bacteria M. luteus at MIC 
625 µg/ml, and ar-himachalene 9 and γ-de-
hydro-ar-himachalene 14 against B. subtilis 
at MIC 375 µg/ml and 1500 µg/ml, respec-
tively. Non aromatic α-himachalene 13 was 
more active than aromatic himachalenes 
against both bacterial and fungal cultures. 
Insertion of carbonyl group at 5th position of 
α-dehydro-ar-himachalene 11 slightly en-
hanced the activity against B. subtilis, M. lu-
teus, and S. aureus. Conversely, the substitu-
tion of carbonyl group of substituted benzo-
cycoheptenone 15 by imine group (16a-16e) 
displayed a noticeable improvement in their 
antibacterial activity against B. subtilis, M. 
luteus and S. aureus with MIC ranging from 
46.8-750 µg/ml. Antifungal activity of these 
compounds against A. sydowii, A. parasiticus 
and A. ochraceous was also high with MIC 
23.4-187.5 µg/ml as reported against A. fu-
migatus for himachalol and other derivatives 
from Cedrus (Parveen et al., 2010; Chow-
dhry et al., 1997).  
The aromatized compounds, however, 
showed low activity against Aspergillus spp. 
High antimicrobial activity observed for 
compounds 16a-16e indicated that the nature 
of imine group at C-5 position markedly af-
fects the activity profile of those compounds. 
The imine substituent 16c exhibited antimi-
crobial activity higher than 16a possibly due 
to its electron releasing effect. No activity 
was observed against C. albicans and I. ori-
entalis except for the compound 16c which 
exhibited a broad spectrum antifungal activi-
ty. Antimicrobial activity of Cedrus extracts 
and essential oils has been previously report-
ed particularly against S. aureus, B. subtilis, 
E. coli, P. aeruginosa and fungi of genus 
Aspergillus (Chowdhry et al., 1997; Pawar et 
al., 2007; Zeng et al., 2011). However, there 
are no reports on the antimicrobial properties 
of mentioned aryl himachalene derivatives.  
 
 
Table 1: Synthesis of novel imine derivatives 
(16a-16e) of aryl himachalene 
Entry Amine Product (16) Yielda (%)
H2N
NH2
H2N
CH3NH2
N
O
NH2
1
2
3
4
5
N
N
N
N
N
N
O
74
78
71
79
65
16a
16b
16c
16d
16e   
aIsolated yield 
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Table 2: Antimicrobial activity of derivatives of α-dehydro-ar-himachalene by broth microdilution  
method against standard microbial cultures (μg/ml) 
Test  
organism 
Test compound 
 10 11 12 13 14 9 15 16a 16b 16c 16d 16e Ampicillin /Nystatinb 
E. coli 
MIC - - - - - - - 3000 - 3000 - - 31.3 
MMC - - - - - - - - - - - - 62.5 
E.  
cloacae 
MIC - - - 312.5 - - - 3000 - 1500 - - 2000 
MMC - - - 625 - - - - 3000 3000 - - - 
B. subtilis 
MIC - - - 312.5 375 1500 187.5 187.5 187.5 46.8 187.5 - 7.8 
MMC - - - 625 750 3000 375 375 375 93.75 375 - 15.6 
B.  
cepacea 
MIC - - - 312.5 - - - - - - - - 2000 
MMC - - - 625 - - - - - - - - - 
M. luteus 
MIC - - 625 156.2 3000 - 375 750 750 93.75 187.5 - 3.9 
MMC - - 2500 1250 - - 750 1500 1500 187.5 375 - 7.8 
S. aureus 
MIC - - - 312.5 - - 750 750 750 375 3000 - 3.9 
MMC - - - 625 - - 3000 3000 3000 750 - - 3.9 
P. aeru-
ginosa 
MIC - - - 2500 - - - - - 3000 - - 1000 
MMC - - - - - - - - - - - - 2000 
K. pneu-
moniae 
MIC - - - - - - - - - - - - 2000 
MMC - - - - - - - - 3000 - - - - 
A. niger 
MIC - - - - 3000 3000 3000 750 750 187.5 1500 750 15.6 
MMC - - - - - - - 1500 1500 1500 - - 62.5 
A. sydowii 
MIC 312.5 1250 1250 625 750 750 187.5 23.4 187.5 46.8 375 375 3.9 
MMC - - - - - - 1500 750 750 187.5 3000 3000 3.9 
A. parasit-
icus 
MIC 1250 - 1250 1250 1500 375 750 187.5 93.75 46.8 750 375 100 
MMC - - - - - 3000 - 3000 3000 750 - - 200 
A. ochra-
ceous 
MIC 156.2 1250 625 625 750 375 750 187.5 93.75 46.8 375 375 62.5 
MMC - - - - - - - 3000 3000 375 - - 125 
A. flavus 
MIC 1250 - 2500 2500 1500 750 1500 750 375 375 1500 1500 62.5 
MMC - - - - - - - - - 3000 - - 62.5 
T. rubrum 
MIC - 1250 1250 1250 1250 1250 1250 1250 1250 625 - - 31.3 
MMC - - 2500 2500 - 2500 - - - 1250 - - 62.5 
C.  
albicans 
MIC - - - - - - - - - 187.5 - - 7.8 
MMC - - - - - - - - - 750 - - 7.8 
I.  
orientalis 
MIC - - - 1250 - - - - - 187.5 - - 31.3 
MMC - - - - - - - - - 375 - - 31.3 
aAntibiotic against gram positive and gram negative bacteria; bAntibiotic against fungi  
-: No activity; MIC= Minimum inhibitory concentration; MMC = Minimum microcidal concentration 
 
 
CONCLUSION 
In conclusion, analogues of aryl hima-
chalenes were synthesized from readily 
available naturally occurring isomeric mix-
ture of himachalenes via α-dehydro-ar-
himachalene. Aromatization of himachalenes 
slightly increased the antibacterial activity 
which was further enhanced after insertion of 
imine moiety in novel imine compounds 
(16a-16e). The imine substituent containing 
isobutyl group 16c showed the highest ac-
tivity amongst tested compounds. These de-
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rivatives could find potential in biological 
applications for drug design and develop-
ment. 
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